Herpes simplex virus-infected squamous cell carcinoma: a case report

BMC Infect Dis. 2022 Jan 4;22(1):25. doi: 10.1186/s12879-021-06995-8.

Abstract

Background: Herpes simplex virus (HSV)-1 is a highly prevalent, non-oncogenic virus that has higher morbidity in immunocompromised hosts. Its most common clinical manifestation is superficial ulceration of the integument or mucus membranes.

Case presentation: A 65-year-old woman with a history of acute myelogenous leukemia treated with allogenic peripheral blood stem cell transplant presented for resection of an ulcerated buccal squamous cell carcinoma. We report a case of HSV-1-infected malignant cells discovered on histopathological examination of the carcinoma specimen ultimately treated with valacyclovir.

Conclusions: HSV-1 is not considered an oncogenic virus itself but may increase risk of malignant progression. Cancer cells are vulnerable to superimposed viral infections, including HSV-1, which likely led to the findings in this case.

Keywords: Case report; Herpes simplex virus; Squamous cell carcinoma; Stem cell transplant.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Squamous Cell*
  • Female
  • Herpes Simplex* / diagnosis
  • Herpes Simplex* / drug therapy
  • Herpesvirus 1, Human*
  • Humans
  • Immunocompromised Host
  • Valacyclovir

Substances

  • Valacyclovir